Did a targeted drug help leukemia patients stay cancer-free longer after transplant?
NCT ID NCT06734585
First seen Oct 31, 2025 · Last updated May 06, 2026 · Updated 32 times
Summary
This study looked at people with a specific genetic form of acute myeloid leukemia (FLT3-mutated) whose cancer returned or didn't respond to treatment. Researchers compared those who took the drug gilteritinib after a stem cell transplant to those who received standard care, using medical records from 2015 to 2022. The goal was to see if gilteritinib helped patients stay cancer-free longer. No new treatments were given—only existing data was collected and analyzed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AU61001
Melbourne, Australia
-
AU61002
Melbourne, Australia
-
BR55001
São Paulo, Brazil
-
BR55002
Porto Alegre, Brazil
-
BR55003
São Paulo, Brazil
-
BR55004
Fortaleza, Brazil
-
CN86001
Tianjin, China
-
CN86003
Shanghai, China
-
CN86004
Suzhou, China
-
HK852001
Hong Kong, Hong Kong
-
KR82001
Seoul, South Korea
-
KR82002
Seoul, South Korea
-
KR82003
Seoul, South Korea
-
KR82004
Busan, South Korea
-
KR82005
Gwangju, South Korea
-
TW88601
Taipei, Taiwan
-
TW88602
Tainan, Taiwan
-
TW88603
Taichung, Taiwan
Conditions
Explore the condition pages connected to this study.